5.42
-0.37
(-6.39%)
At close: January 24 at 4:00:01 PM EST
5.42
0.00
(0.00%)
After hours: January 24 at 4:01:32 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Sale | Oct 29, 2024 | 176,692 |
| CONNER EDWARD R Officer | Conversion of Exercise of derivative security | Nov 8, 2024 | 0 |
| DITTMAN JENNIFER Officer | Conversion of Exercise of derivative security | Jun 7, 2024 | 0 |
| HOLLES NATALIE C Chief Executive Officer | Conversion of Exercise of derivative security | May 9, 2024 | 1,218,840 |
| PERSON JULIE Officer | Conversion of Exercise of derivative security | Sep 19, 2024 | 0 |
Related Tickers
DNTH Dianthus Therapeutics, Inc.
21.21
-5.10%
GYRE Gyre Therapeutics, Inc.
11.19
+8.22%
PEPG PepGen Inc.
1.9400
-1.02%
ATXS Astria Therapeutics, Inc.
7.41
-3.52%
RAPP Rapport Therapeutics, Inc.
13.90
-3.72%
IRON Disc Medicine, Inc.
57.45
+0.95%
UPB Upstream Bio, Inc.
10.39
-5.33%
ADAG Adagene Inc.
1.9300
+9.96%
TRDA Entrada Therapeutics, Inc.
12.84
-1.00%
LXEO Lexeo Therapeutics, Inc.
5.58
+3.72%